Início › Carcinoma de Células Escamosas de Cabeça e Pescoço › Minnesota

Ensaios clínicos de Carcinoma de Células Escamosas de Cabeça e Pescoço em Minnesota

23 estudos para Carcinoma de Células Escamosas de Cabeça e Pescoço estão buscando participantes em locais em Minnesota.

Cidades em Minnesota

Texto oficial do estudo (Inglês)

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Mayo Clinic Health System in Albert Lea, Albert Lea
Sanford Joe Lueken Cancer Center, Bemidji
Mayo Clinic Health Systems-Mankato, Mankato
e mais 2

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06992427

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Site #0156, Maplewood
Site #0146, Rochester

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06788990

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #68, Rochester

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT05176483

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Sanford Joe Lueken Cancer Center, Bemidji
Minnesota Oncology - Burnsville, Burnsville
Mercy Hospital, Coon Rapids
e mais 7

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06589804

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Sanford Joe Lueken Cancer Center, Bemidji
Essentia Health Saint Joseph's Medical Center, Brainerd
Minnesota Oncology - Burnsville, Burnsville
e mais 18

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05136196

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Sanford Joe Lueken Cancer Center, Bemidji

RecrutandoFase 2

Idades de 18 a 79 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT04671667

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Minnesota Oncology and Hematology PA, Minneapolis

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT05267626

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Mayo Rochester, Rochester

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07109726

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Riverwood Healthcare Center, Aitkin
Essentia Health - Baxter Clinic, Baxter
Sanford Joe Lueken Cancer Center, Bemidji
e mais 48

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT02734537

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Mayo Clinic (Rochester), Rochester

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Mayo Clinic, Rochester

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT06657222

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Mayo Clinic Rochester, Rochester

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06163534

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

University of Minnesota Masonic Cancer Center, Minneapolis

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT07216105

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Normunity Investigational Site, Minneapolis

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07182149

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Mayo Clinic in Rochester, Rochester

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT04333537

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Miller-Dwan Hospital, Duluth

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT06532279

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

M Health Fairview University of Minnesota Medical Center, Minneapolis

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT06330064

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Allina Health Cancer Institute - Mercy Hospital, Coon Rapids
Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Allina Health Cancer Institute - United Hospital, Saint Paul
e mais 1

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT04389632

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

M Health Fairview University of Minnesota Medical Center - East Bank /ID# 276200, Minneapolis

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 23 de jun. de 2026 · NCT05005403

Oropharynx (OPX) Biomarker Trial

Mayo Clinic in Rochester, Rochester

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 22 de abr. de 2026 · NCT06356272

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Research Site 121, Saint Paul

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 21 de nov. de 2025 · NCT05914116

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Mayo Clinic, Rochester

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2025 · NCT06682793

A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors

Mayo Clinic Rochester, Rochester

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2024 · NCT06259552

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.